Phlegmon overview

Revision as of 21:15, 10 December 2012 by Hardik Patel (talk | contribs)
Jump to navigation Jump to search

Phlegmon Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Phlegmon from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Phlegmon overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Phlegmon overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onPhlegmon overview

CDC on Phlegmon overview

Phlegmon overview in the news

Blogs on Phlegmon overview

Directions to Hospitals Treating Phlegmon

Risk calculators and risk factors for Phlegmon overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Phlegmon is a spreading diffuse inflammatory process with formation of suppurative/purulent exudate or pus.


Pathophysiology

Factors affecting the development of phlegmons are virulence of bacteria and human's immunity strength defenses.

Causes

Phlegmon is commonly caused by bacteria - staphylococci, streptococci, pneumococci, spore and non-spore forming anaerobes, etc.

History and Symptoms

Systemic features of infection like increased body temperature (up to 38-40°C), general fatigue, chills, sweatings, headache, and loss of appetite may be present.

Physical Examination

Inflammatory signs - dolor(localized pain), calor(increase local tissue temperature), rubor (skin redness/hyperemia), tumor(either clear or non-clear bordered tissue swelling), functio laesa(diminish affected function) may be present. Severity of patient condition with phlegmons is directly proportional to the degree of intoxication level i.e the severe the condition, the higher degree of intoxication level.

Laboratory Findings

The main goal of treatment is to remove the cause of phlegmonous process in order to achieve effective treatment and prevention of recurrence. If patients condition is mild and the signs of inflammatory process is presence without signs of infiltrates, then conservative treatment with antibiotics is sufficient.

Medical Therapy

The main goal of treatment is to remove the cause of phlegmonous process in order to achieve effective treatment and prevention of recurrence. If patients condition is mild and the signs of inflammatory process is presence without signs of infiltrates, then conservative treatment with antibiotics is sufficient.

References

Template:WH Template:WS